Reports
Global JE (Japanese Encephalitis) Vaccine Market Forecast: By Type: Inactivated, Recombinant, Live attenuated; By Distribution Channel: Hospitals, Retail, Online; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Competitive Landscape; 2024-2032
Global JE (Japanese Encephalitis) Vaccine Market Outlook
The global JE (Japanese encephalitis) vaccine market was estimated to value at USD 215.15 million in 2023. It is expected to grow at a CAGR of 7.6% during the forecast period of 2024-2032 to reach a value of USD 329.90 million in 2032.
The increasing mosquito nuisance, rising awareness, and the growing investment in the healthcare sector by the governments across the nations are some of the significant factors contributing to the growth of the global JE (Japanese encephalitis) vaccine market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
Japanese encephalitis (JE) vaccine is an inactivated vaccine that provides protection against Japanese encephalitis, an infection of the brain caused by the Japanese encephalitis virus (JEV), generally spread by mosquitoes.
The global JE (Japanese encephalitis) vaccine industry can be broadly categorised based on segments like types, distribution channels, and regions.
- Type:
- Inactivated
- Recombinant
- Live attenuated
- Distribution Channel:
- Hospitals
- Retail
- Online
The EMR report looks into the regional markets of global JE (Japanese encephalitis) vaccine market like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Market Analysis
The increase in the prevalence and incidence of Japanese encephalitis disease is driving the demand for global JE (Japanese encephalitis) vaccines globally. With the growing trend of routine immunisation or vaccination, the industry is witnessing a strong demand for global JE (Japanese encephalitis) vaccines. Further, the inclusion of Japanese encephalitis vaccination in national immunisation programmes by the governments across the nation is expected to be one of the significant growth drivers for the industry over the forecast period. The growing investment in R&D of these vaccines is aiding the industry growth. Within the Asia Pacific, China and India are at high risk of Japanese encephalitis. Thus, the governments of these countries are carrying out mass vaccinations, providing a further impetus to the industry. However, the lack of awareness may hamper the industry growth over the forecast period.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global JE (Japanese encephalitis) vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Valneva SE
- Bharat Biotech International Limited
- Sanofi
- Chengdu Institute of Biological Products Co., Ltd.
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Distribution Channel, Region |
| Breakup by Type | Inactivated, Recombinant, Live attenuated |
| Breakup by Distribution Channel | Hospitals, Retail, Online |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Valneva SE, Sanofi, Bharat Biotech International Limited, Chengdu Institute of Biological Products Co. Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global JE (Japanese Encephalitis) Vaccine Market Analysis
8.1 Key Industry Highlights
8.2 Global JE (Japanese Encephalitis) Vaccine Historical Market (2018-2023)
8.3 Global JE (Japanese Encephalitis) Vaccine Market Forecast (2024-2032)
8.4 Global JE (Japanese Encephalitis) Vaccine Market by Type
8.4.1 Inactivated
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2023)
8.4.1.3 Forecast Trend (2024-2032)
8.4.2 Recombinant
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2023)
8.4.2.3 Forecast Trend (2024-2032)
8.4.3 Live Attenuated
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2023)
8.4.3.3 Forecast Trend (2024-2032)
8.5 Global JE (Japanese Encephalitis) Vaccine Market by Distribution Channel
8.5.1 Hospitals
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2023)
8.5.1.3 Forecast Trend (2024-2032)
8.5.2 Retail
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2023)
8.5.2.3 Forecast Trend (2024-2032)
8.5.3 Online
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2023)
8.5.3.3 Forecast Trend (2024-2032)
8.6 Global JE (Japanese Encephalitis) Vaccine Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2023)
8.6.1.3 Forecast Trend (2024-2032)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2023)
8.6.2.3 Forecast Trend (2024-2032)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2023)
8.6.3.3 Forecast Trend (2024-2032)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2023)
8.6.4.3 Forecast Trend (2024-2032)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2023)
8.6.5.3 Forecast Trend (2024-2032)
9 North America JE (Japanese Encephalitis) Vaccine Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2023)
9.1.3 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2023)
9.2.3 Forecast Trend (2024-2032)
10 Europe JE (Japanese Encephalitis) Vaccine Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2023)
10.1.3 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2023)
10.2.3 Forecast Trend (2024-2032)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2023)
10.3.3 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2023)
10.4.3 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific JE (Japanese Encephalitis) Vaccine Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2023)
11.1.3 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2023)
11.2.3 Forecast Trend (2024-2032)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2023)
11.3.3 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2023)
11.4.3 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2023)
11.5.3 Forecast Trend (2024-2032)
11.6 Others
12 Latin America JE ( Japanese Encephalitis) Vaccine Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2023)
12.1.3 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2023)
12.2.3 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2023)
12.3.3 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa JE (Japanese Encephalitis) Vaccine Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2023)
13.1.3 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2023)
13.2.3 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2023)
13.3.3 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2023)
13.4.3 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Valneva SE
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Sanofi
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Bharat Biotech International Limited
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Chengdu Institute of Biological Products Co. Ltd.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global JE (Japanese Encephalitis) Vaccine Market: Key Industry Highlights, 2017 and 2027
2. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
5. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
6. Global JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Region (USD Million), 2018-2023
7. Global JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Region (USD Million), 2024-2032
8. North America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
9. North America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
10. Europe JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
11. Europe JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Asia Pacific JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
13. Asia Pacific JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Latin America JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
15. Latin America JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Middle East and Africa JE (Japanese Encephalitis) Vaccine Historical Market: Breakup by Country (USD Million), 2018-2023
17. Middle East and Africa JE (Japanese Encephalitis) Vaccine Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Global JE (Japanese Encephalitis) Vaccine Market Structure
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 7.6% between 2022 and 2027.
The major drivers of the market, such as a rise in incidences of Japanese encephalitis disease, increasing health awareness, rising demand from the developing regions, increased government investments in the medical sector, and the growing technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the market include the growing R&D activities, growing demand for routine immunisation, and initiation of national immunisation programmes by the governments across several nations.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Inactivated, recombinant, and live attenuated vaccines are the major types of the product in the market.
The leading distribution channels in the market include hospitals, retail, and online.
The major players in the market are Valneva SE, Sanofi, Bharat Biotech International Limited, Chengdu Institute of Biological Products Co. Ltd., among others.
Analyst Review
The global JE (Japanese encephalitis) vaccine market was estimated to value at USD 215.15 million in 2023. It is expected to grow at a CAGR of 7.6% during the forecast period of 2024-2032 to reach a value of USD 329.90 million in 2032. The market is being driven by the rising prevalence of Japanese encephalitis due to increasing mosquito nuisance. Aided by the growing knowledge of routine immunisation and favourable government initiatives, the market is expected to witness a growth during the forecast period.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its type, the market can be segmented into inactivated, recombinant, and live attenuated vaccines. On the basis of distribution channel, the market is divided into hospitals, retail, and online. The major regional markets for global JE (Japanese encephalitis) vaccine are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Valneva SE, Sanofi, Bharat Biotech International Limited, Chengdu Institute of Biological Products Co. Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$2799
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER